PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

http://ww2.peerview.com

Eine durchschnittliche Folge dieses Podcasts dauert 1h1m. Bisher sind 475 Folge(n) erschienen. Alle 3 Tage erscheint eine Folge dieses Podcasts.

Gesamtlänge aller Episoden: 19 days 1 hour 14 minutes

subscribe
share





Sumanta Kumar Pal, MD - New Data and Clinical Context: An Update on Renal Cell Carcinoma Care in Early Through Advanced Disease


Go online to PeerView.com/YFW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







   29m
 
 
share







   1h4m
 
 

Jacob Sands, MD - Making the Most of Treatment Advances in SCLC: New Standards, Practicalities of Care, and Hope on the Horizon


Go online to PeerView.com/FJX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







   1h31m
 
 
share







   1h33m
 
 

Gail J. Roboz, MD - Clinical Consults on Modern AML Therapy: Where Precision Care Meets Potent Therapeutics


Go online to PeerView.com/GXY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







   1h31m
 
 

Jason J. Luke, MD, FACP / Geoffrey T. Gibney, MD - Building Better Models for Melanoma Care: Continued Progress With Immunotherapy in Resectable and Unresectable Disease


Go online to PeerView.com/GZJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







   1h5m
 
 

Joyce O’Shaughnessy, MD - Expanding the Benefits of Checkpoint Inhibitors and Targeted Agents in the Treatment Arsenal for Triple-Negative Breast Cancer


Go online to PeerView.com/EKR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







   1h39m
 
 

Sara Hurvitz, MD - Making Progress in Early and Advanced HER2-Positive Breast Cancer: Leveraging HER2-Targeted Therapies and Modern Care Principles to Improve Clinical Outcomes and Health Equity


Go online to PeerView.com/SAA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







   1h35m
 
 

Matthew S. Davids, MD, MMSc - Pushing Therapeutic Boundaries in CLL: The Convergence of Targeted Therapy, Novel Combinations, and Precision Medicine in Patient Care


Go online to PeerView.com/JWG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







   1h29m
 
 

William G. Wierda, MD, PhD - New Standards for CLL Care With BTK Inhibitors: Using Evidence to Make Personalized Treatment Choices


Go online to PeerView.com/SYN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share







   1h36m